Larvol Veri

CANCER:

Juvenile Myelomonocytic Leukemia

Related cancers:

‹

Leukemia (1457)

Acute Myelogenous Leukemia (648)

Acute Lymphocytic Leukemia (283)

Chronic Myeloid Leukemia (245)

Chronic Lymphocytic Leukemia (217)

B Acute Lymphoblastic Leukemia (109)

Childhood B Acute Lymphoblastic Leukemia (36)

T Acute Lymphoblastic Leukemia (32)

Hairy Cell Leukemia (16)

Chronic Myelomonocytic Leukemia (15)

Prolymphocytic Leukemia (12)

Acute Promyelocytic Leukemia (9)

Chronic Eosinophilic Leukemia (4)

Chronic Neutrophilic Leukemia (3)

Leukemia (1457)

Acute Myelogenous Leukemia (648)

Acute Lymphocytic Leukemia (283)

Chronic Myeloid Leukemia (245)

Chronic Lymphocytic Leukemia (217)

B Acute Lymphoblastic Leukemia (109)

Childhood B Acute Lymphoblastic Leukemia (36)

T Acute Lymphoblastic Leukemia (32)

Hairy Cell Leukemia (16)

Chronic Myelomonocytic Leukemia (15)

Prolymphocytic Leukemia (12)

Acute Promyelocytic Leukemia (9)

Chronic Eosinophilic Leukemia (4)

Chronic Neutrophilic Leukemia (3)

›

KRAS mutation KRAS mutation	Juvenile Myelomonocytic Leukemia Juvenile Myelomonocytic Leukemia	decitabine Sensitive: C4 – Case Studies decitabine Sensitive : C4
SETBP1 mutation + NRAS mutation SETBP1 mutation + NRAS mutation	Juvenile Myelomonocytic Leukemia Juvenile Myelomonocytic Leukemia	trametinib Sensitive: D – Preclinical trametinib Sensitive : D

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and